Close

Analyst Ratings for Oncternal Therapeutics (ONCT) [Neutrals]

ONCT Rating Summary

ONCT Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ONCT
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $11.10 (+23.3%) * Over Last 12-Mos
Rating Score: 7.1 / 10   Percentile Rank: 77%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/4/2023 Maxim Group Naureen Quibria Downgrade Hold
(Buy)
N/A
(N/A)
0.79
(9.00)
1039.24% Details
4/4/2023 Oppenheimer Hartaj Singh Downgrade Perform
(Outperform)
N/A
(N/A)
0.79
(9.00)
1039.24% Details
Like ONCT Ratings? Also take a look at AMGN, CAT, MMM, TRV

ONCT Ratings News